EAST WINDSOR, N.J.--(BUSINESS WIRE)--NexMed, Inc. (Nasdaq: NEXM), a developer of innovative transdermal products based on its proprietary NexACT® drug delivery technology, today announced that Mark Westgate, Chief Financial Officer of the Company, will be presenting an overview of NexMed, Inc. at the FTN Midwest Securities Corp. 2007 Health Care Conference on Tuesday, June 5, 2007 at 11:20am Eastern Time at The Four Seasons Hotel in New York City.
